New Abbott Aluvia(R) Tablet for Treatment of HIV Available in South Africa

03.06.2008 06:40:05
Abbott Laboratories: Johannesburg, South Africa (ots/PRNewswire) - - More than 5 Million South Africans Living with HIV Gain Access to First and Only Co-formulated, Non-refrigerated Protease Inhibitor Abbott (NYSE: ABT) today announced that the new tablet ...

Lesen Sie hier weiter... |  Drucken |  PDF

Ähnliche Artikel




Presseportal: Abbott Laboratories - Abbott meldet Aufhebung des ...

05.08.08 21:26 Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily 06:02 New Abbott Aluvia(R) Tablet for Treatment of HIV Available in South Africa


MedCrawler.de - Die Suchmaschine für Medizin und Gesundheit

MedCrawler.de - Die Suchmaschine für Medizin und Gesundheit - indiziert auschliesslich deutschsprachige Seiten mit New Abbott Aluvia(R) Tablet for


ots.at: das APA-OTS-Portal für multimediale Presseaussendungen

New Abbott Aluvia(R) Tablet for Treatment of HIV Available in South Africa = 03.06.2008 / 06:04 New Abbott Kaletra(R) (lopinavir/ritonavir) Lower-Strength


Abbott Laboratories Pressemitteilungen News | PresseEcho.de

New Abbott Aluvia(R) Tablet for Treatment of HIV Available in South Africa that the new tablet formulation of its protease inhibitor Aluvia(R) (lopinavir


Presseportal.de - Abbott Laboratories

New Abbott Aluvia(R) Tablet for Treatment of HIV Available in South Africa New Abbott Kaletra(R) (lopinavir/ritonavir) Lower-Strength Tablet for Pediatric